AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
for Epithelial Ovarian Cancer
17 locations incl. Fort Lauderdale
Sponsor: AstraZeneca
Sex: Female·Age: 18+
Code: NCT07218809·Phase 3·Recruiting